Press release
Psoriasis Therapeutics Market worth $41.55 billion by 2030, growing at a CAGR of 9.77% - Exclusive Report by 360iResearch
Psoriasis Therapeutics Market | 360iResearch
Request a Free Sample Report @ https://www.360iresearch.com/library/intelligence/psoriasis-therapeutics?utm_source=openpr&utm_medium=referral&utm_campaign=sample
The psoriasis therapeutics market encompasses various treatments designed to manage the symptoms and progression of psoriasis, a chronic autoimmune skin condition marked by red, scaly patches. This market includes topical treatments, systemic medications, biologic drugs, and phototherapy, catering to both over-the-counter and prescription needs. Effective therapeutic options are essential for improving patients' quality of life and managing associated comorbidities such as arthritis and cardiovascular diseases. Applications range from creams and ointments for topical use to oral and injected medications, advanced biologics targeting specific parts of the immune system, and phototherapy involving controlled ultraviolet light exposure. Key growth factors driving the market include the rising prevalence of psoriasis, advancements in biologics offering more targeted treatments, and growing public awareness of treatment options. Potential opportunities lie in the development of next-generation biologics, personalized medicine leveraging genetic insights, and the expansion of telemedicine services. However, challenges such as the high cost of advanced therapies, potential side effects, strict regulatory processes, and intense market competition in developed regions pose significant barriers to growth. Areas for innovation include continued advancements in biologics, genomic research for better treatment prediction, development of combination therapies, improvement in drug delivery systems, and the use of artificial intelligence and big data for predictive modeling. The market is characterized by rapid evolution, high R&D investment, and regulatory scrutiny, requiring companies to focus on innovation, accessibility, and patient-centric approaches to sustain and grow their presence. The market offers vast opportunities driven by medical needs and technological advancements, but navigating high costs and regulatory barriers is crucial for success.
Inquire Before Buying @ https://www.360iresearch.com/library/intelligence/psoriasis-therapeutics?utm_source=openpr&utm_medium=referral&utm_campaign=inquire
Market Segmentation & Coverage:
This research report categorizes the Psoriasis Therapeutics Market in order to forecast the revenues and analyze trends in each of following sub-markets:
Based on Molecule, market is studied across Biologics and Small Molecules.
Based on Route of Administration, market is studied across Oral, Parenteral, and Topical.
Based on Dosage Forms, market is studied across Liquid, Semi-Solid, and Solid.
Based on Mechanism of Action, market is studied across IL Blocker, PDE4 Inhibitors, and TNF Inhibitors.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Key Company Profiles:
The report delves into recent significant developments in the Psoriasis Therapeutics Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Amgen, Inc., Astellas Pharma Inc., AstraZeneca Plc, Bausch Health Companies Inc., Boehringer Ingelheim International GmbH, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Johnson & Johnson services, inc, LEO Pharma A/S, Merck & Co., Inc., Novartis AG, Pfizer Inc, and Sun Pharmaceutical Industries Limited.
Introducing ThinkMi Query: Revolutionizing Market Intelligence with AI-Powered Insights for the Psoriasis Therapeutics Market
We proudly unveil ThinkMi Query, a cutting-edge AI product designed to transform how businesses interact with the Psoriasis Therapeutics Market. ThinkMi Query stands out as your premier market intelligence partner, delivering unparalleled insights with the power of artificial intelligence. Whether deciphering market trends or offering actionable intelligence, ThinkMi Query is engineered to provide precise, relevant answers to your most critical business questions. This revolutionary tool is more than just an information source; it's a strategic asset that empowers your decision-making with up-to-the-minute data, ensuring you stay ahead in the fiercely competitive Psoriasis Therapeutics Market. Embrace the future of market analysis with ThinkMi Query, where informed decisions lead to remarkable growth.
Ask Question to ThinkMi Query @ https://www.360iresearch.com/library/intelligence/psoriasis-therapeutics?utm_source=openpr&utm_medium=referral&utm_campaign=query
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Psoriasis Therapeutics Market, by Molecule
7. Psoriasis Therapeutics Market, by Route of Administration
8. Psoriasis Therapeutics Market, by Dosage Forms
9. Psoriasis Therapeutics Market, by Mechanism of Action
10. Americas Psoriasis Therapeutics Market
11. Asia-Pacific Psoriasis Therapeutics Market
12. Europe, Middle East & Africa Psoriasis Therapeutics Market
13. Competitive Landscape
14. Competitive Portfolio
Read More @ https://www.360iresearch.com/library/intelligence/psoriasis-therapeutics?utm_source=openpr&utm_medium=referral&utm_campaign=analyst
Contact 360iResearch
Mr. Ketan Rohom
Sales & Marketing,
Office No. 519, Nyati Empress,
Opposite Phoenix Market City,
Vimannagar, Pune, Maharashtra,
India - 411014.
sales@360iresearch.com
+1-530-264-8485
+91-922-607-7550
About 360iResearch
360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.
We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset - our people.
Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.
Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Psoriasis Therapeutics Market worth $41.55 billion by 2030, growing at a CAGR of 9.77% - Exclusive Report by 360iResearch here
News-ID: 3581570 • Views: …
More Releases from 360iResearch
Rising Incidence of Human Metapneumovirus in Vulnerable Populations Boosts Globa …
In recent years, the silent ascent of human metapneumovirus (HMPV) infections has begun to capture significant attention within the realm of infectious diseases. As we advance in medical science, unraveling complexities of age-old pathogens like common influenza or emerging illnesses like COVID-19, a critical discourse has been emerging around HMPV. Particularly, there seems to be a burgeoning acknowledgment of its growing impact on vulnerable global populations, propelling an increased demand…
The Meat Alternatives Market size was estimated at USD 9.39 billion in 2023 and …
From Appetite to Advocacy: The Rising Demand for Meat Alternatives
In recent years, the global food industry has been undergoing a remarkable transformation, driven primarily by an increasing consumer demand for healthier, sustainable, and ethically sourced food products. This seismic shift has brought traditional meat alternatives and high-protein plant-based foods into the spotlight. As the world becomes more conscious of the implications of meat consumption on health and the environment, the…
The Mobility-as-a-Service Market size was estimated at USD 264.80 billion in 202 …
Unpacking the Surge in Investments and Collaborations to Bolster Mobility-as-a-Service
In recent years, as urban landscapes continually evolve, a transformative shift known as Mobility-as-a-Service (MaaS) has reshaped the way we perceive transportation. Marked by the integration of various forms of transport services into a single accessible on-demand mobility solution, MaaS is rapidly gaining traction across global cities. As an emerging paradigm, it's not just shaping the future of travel but also…
The Data Center Services Market size was estimated at USD 56.65 billion in 2023 …
Smart City Revolutions: Why Data Center Colocation is the Future Backbone
In the era of digital transformation, urban landscapes across the globe are undergoing a seismic shift toward becoming "smart cities." The concept of a smart city revolves around using digital technology, IoT (Internet of Things), AI, and data analytics at an unprecedented scale to improve urban infrastructure, manage resources efficiently, and enhance the quality of life for citizens. A vital…
More Releases for Psoriasis
Psoriasis Vulgaris Market
Introduction
Psoriasis vulgaris, also known as plaque psoriasis, is the most common form of psoriasis, accounting for nearly 80-90% of all cases. It is a chronic autoimmune condition marked by red, scaly plaques that can cause significant physical discomfort and emotional distress. Affecting millions worldwide, psoriasis vulgaris is increasingly recognized as both a dermatological and systemic disease due to its association with arthritis, cardiovascular disease, and metabolic syndrome.
The global psoriasis vulgaris…
Major Growth Driver Identified in 2025 Psoriasis Market: Prevalence Of Psoriasis …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Psoriasis Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the size of the psoriasis market has experienced a significant increase. It is projected to escalate from $26.56 billion in 2024 to $29.5 billion in 2025, reflecting a compound annual growth rate (CAGR)…
Prevalence Of Psoriasis Driving Market Growth: Key Factor Driving The Growth In …
The Psoriasis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Psoriasis Market Size During the Forecast Period?
The psoriasis market has seen rapid growth in recent years. It will increase from $26.56 billion in 2024 to $29.5 billion in 2025, at a…
Plaque Psoriasis to Hold 85% Share of Psoriasis Drugs Market through 2031
Psoriasis is a chronic inflammatory skin disease that occurs due to genetic disposition and environmental factors. Psoriasis is a systemic disease associated with psychological, metabolic, arthritic, and cardiovascular comorbidities. On an average, psoriasis affects around 2 - 3% of the population globally.
Plaque psoriasis, being the number one and most common indication, held nearly 85% share of the US$ 11.37 Bn psoriasis drugs market in 2021, with the market estimated to…
Psoriasis - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Psoriasis - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Psoriasis - Pipeline Review, H1 2017, provides an overview of the Psoriasis (Immunology) pipeline landscape.
Psoriasis is a chronic skin condition caused by an overactive immune system. Symptoms of the disease include shedding of cells, flared up…
Global Psoriasis Market with Focus on Plaque Psoriasis: Outlook to 2020
Psoriasis is a chronic inflammatory skin disease primarily causing scaling and inflammation of skin, characterized by sharply demarcated, scaly, red skin lesions most often on the elbows, knees, scalps, hands and feet. It occurs when the body’s immune system sends out faulty signals that speed up the growth cycle of skin cells. Psoriasis has been majorly classified into Plaque psoriasis, Guttate psoriasis, Inverse psoriasis, Pustular psoriasis and Erytherodermic psoriasis. It…
